Developer docs
API playgroundTry for free, no card

Search company profiles

nuroflux

Full company profile

uuid0004vfl

Namestring
nuroflux
Websiteurl
nuroflux.com
Company typeenum
Private
Founded yearint
2021
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
neurological monitoring devices, wearable brain monitoring, stroke detection technology, continuous EEG monitoring, brain blood flow monitoring
Industry4 codes
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Neurological Monitoring Medical Devices
No data
Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Nuroflux develops the nuroflux™ wearable, a proprietary multi-modal device that non-invasively monitors brain activity via electroencephalography (EEG) and brain blood flow via a novel electrocardiography-based metric. The device is designed to provide continuous, real-time monitoring of stroke patients to detect secondary strokes and monitor treatment effectiveness between CT perfusion scans, with future potential for pre-hospital and self-administered remote monitoring.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Current standard care detects neurological deterioration in only 45% of positive cases
+1 more record
Product overview1 text field

Nuroflux offers a single unified wearable product called nuroflux™ — the world's first wearable for non-invasive continuous monitoring of brain activity and brain blood flow. The device uses a proprietary multi-modal system combining EEG and a novel ECG-based metric to provide simultaneous monitoring. It is designed for stroke patients in clinical settings, pre-hospital environments, and remote home monitoring by high-risk patients. Multiple modalities enable rich datasets for deep-learning analysis and predictive models.

Product and service1 record
1nuroflux™ Wearable Monitoring System
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership with The George Institute for Global Health, a leading not-for-profit medical research institute focused on solving major global health challenges including stroke. The collaboration aims to revolutionise stroke patient care and improve outcomes, especially in underserved communities. The institute provides clinical support including neurologist Professor Craig Anderson (President-elect of World Stroke Organisation) and Associate Professor Candice Delcourt.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborating institution providing startup and entrepreneurship support through UNSW Founders program.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborating institution - Remarkable accelerator program supporting startups in the health technology space.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Markets FORE-SIGHT cerebral oximetry technology for non-invasive brain oxygen saturation monitoring in surgical and ICU settings. Competes on the brain blood flow monitoring dimension of nuroflux's multi-modal wearable.

TypeBroad incumbent
Description

Established patient monitoring incumbent with FDA-cleared SedLine EEG-based brain function monitor and O3 regional oximetry for cerebral oxygenation. Competes for the same hospital brain-monitoring budget as nuroflux, but operates across a much broader vital signs portfolio.

TypeDirect peer
Description

Australia-based manufacturer of clinical and research EEG, sleep, and brain monitoring systems. Direct peer in neurological EEG wearables, with comparable product category, customer base (hospitals/research), and origin in the Australian medtech ecosystem.

TypeBroad incumbent
Description

Sells INVOS cerebral/somatic oximetry and BIS brain monitoring systems widely used in operating rooms and ICUs. Direct overlap with nuroflux's continuous brain blood flow and EEG monitoring use cases in hospital settings.

TypeEmerging player
Description

Developer of a portable, point-of-care EEG system for rapid brain monitoring in hospitals and emergency settings. Closely comparable to nuroflux in targeting continuous, accessible EEG-based neurological monitoring outside traditional EEG labs.

TypeEmerging player
Description

Developer of EEG-based, non-invasive handheld devices for traumatic brain injury assessment. Comparable to nuroflux's TBI indication and its approach of using EEG-derived signals for objective brain injury evaluation outside imaging.

TypeEmerging player
Description

Pursues non-invasive, real-time cerebral blood flow assessment using robotic ultrasound. Comparable to nuroflux on the brain blood flow monitoring axis, though using a different sensing modality.

TypeEmerging player
Description

Specialist in non-invasive cerebral and tissue oximetry sensors for clinical and remote monitoring. Overlaps with nuroflux on the non-invasive brain blood flow monitoring use case.

TypeEmerging player
Description

Provides AI-enhanced CT perfusion and MRI imaging software widely used in acute stroke workflows. Adjacent competitor addressing the same stroke monitoring/decision gap, though based on imaging rather than wearable electrophysiology.

TypeEmerging player
Description

Supplies fNIRS-based neuroimaging systems for non-invasive brain activity and hemodynamics monitoring in clinical and research settings. Comparable to nuroflux's multi-modal non-invasive brain monitoring approach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

nuroflux

Neurological Monitoring Medical Devicesnuroflux.com

nuroflux firmographics

Firmographics
Name
nuroflux
Website
https://nuroflux.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

nuroflux industry classification

Industry
Product category
Neurological Monitoring Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Neurological monitoring devices
  • Wearable brain monitoring
  • Stroke detection technology
  • Continuous EEG monitoring
  • Brain blood flow monitoring

Where nuroflux is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Markets served

nuroflux business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

nuroflux product offering

Product offering

Core offering

Nuroflux develops the nuroflux™ wearable, a proprietary multi-modal device that non-invasively monitors brain activity via electroencephalography (EEG) and brain blood flow via a novel electrocardiography-based metric. The device is designed to provide continuous, real-time monitoring of stroke patients to detect secondary strokes and monitor treatment effectiveness between CT perfusion scans, with future potential for pre-hospital and self-administered remote monitoring.

Product overview

Nuroflux offers a single unified wearable product called nuroflux™ — the world's first wearable for non-invasive continuous monitoring of brain activity and brain blood flow. The device uses a proprietary multi-modal system combining EEG and a novel ECG-based metric to provide simultaneous monitoring. It is designed for stroke patients in clinical settings, pre-hospital environments, and remote home monitoring by high-risk patients. Multiple modalities enable rich datasets for deep-learning analysis and predictive models.

Differentiator

Problem solved

Functional benefit

Products and services

  • nuroflux™ Wearable Monitoring System

Quantifiable outcome

  • Current standard care detects neurological deterioration in only 45% of positive cases
  • +1 more outcomes

Companies that use nuroflux

Customer profile

Segments4 records

Ideal customer profiles3 records

nuroflux technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

nuroflux partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • The George Institute for Global HealthcoreStrategic or Co-development PartnerStrategic partnership with The George Institute for Global Health, a leading not-for-profit medical research institute focused on solving major global health challenges including stroke. The collaboration aims to revolutionise stroke patient care and improve outcomes, especially in underserved communities. The institute provides clinical support including neurologist Professor Craig Anderson (President-elect of World Stroke Organisation) and Associate Professor Candice Delcourt.
  • UNSW FoundersminorStrategic or Co-development PartnerCollaborating institution providing startup and entrepreneurship support through UNSW Founders program.
  • RemarkableminorStrategic or Co-development PartnerCollaborating institution - Remarkable accelerator program supporting startups in the health technology space.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

nuroflux competitors and assessment

Company assessment

Broad incumbents

  • Edwards Lifesciences: Markets FORE-SIGHT cerebral oximetry technology for non-invasive brain oxygen saturation monitoring in surgical and ICU settings. Competes on the brain blood flow monitoring dimension of nuroflux's multi-modal wearable.
  • Masimo: Established patient monitoring incumbent with FDA-cleared SedLine EEG-based brain function monitor and O3 regional oximetry for cerebral oxygenation. Competes for the same hospital brain-monitoring budget as nuroflux, but operates across a much broader vital signs portfolio.
  • Medtronic: Sells INVOS cerebral/somatic oximetry and BIS brain monitoring systems widely used in operating rooms and ICUs. Direct overlap with nuroflux's continuous brain blood flow and EEG monitoring use cases in hospital settings.

Direct peers

  • Compumedics: Australia-based manufacturer of clinical and research EEG, sleep, and brain monitoring systems. Direct peer in neurological EEG wearables, with comparable product category, customer base (hospitals/research), and origin in the Australian medtech ecosystem.

Emerging players

  • Ceribell: Developer of a portable, point-of-care EEG system for rapid brain monitoring in hospitals and emergency settings. Closely comparable to nuroflux in targeting continuous, accessible EEG-based neurological monitoring outside traditional EEG labs.
  • BrainScope: Developer of EEG-based, non-invasive handheld devices for traumatic brain injury assessment. Comparable to nuroflux's TBI indication and its approach of using EEG-derived signals for objective brain injury evaluation outside imaging.
  • NovaSignal: Pursues non-invasive, real-time cerebral blood flow assessment using robotic ultrasound. Comparable to nuroflux on the brain blood flow monitoring axis, though using a different sensing modality.
  • Nonin Medical: Specialist in non-invasive cerebral and tissue oximetry sensors for clinical and remote monitoring. Overlaps with nuroflux on the non-invasive brain blood flow monitoring use case.
  • iSchemaView (RAPID): Provides AI-enhanced CT perfusion and MRI imaging software widely used in acute stroke workflows. Adjacent competitor addressing the same stroke monitoring/decision gap, though based on imaging rather than wearable electrophysiology.
  • NIRx Medizintechnik: Supplies fNIRS-based neuroimaging systems for non-invasive brain activity and hemodynamics monitoring in clinical and research settings. Comparable to nuroflux's multi-modal non-invasive brain monitoring approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

nuroflux financial estimates

Financial estimate

Revenue estimate

Valuation estimate

nuroflux leadership team

Management profile

Number of profiles

Profiles11 records

nuroflux funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

nuroflux M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about nuroflux

What does nuroflux do?

Nuroflux develops the nuroflux™ wearable, a proprietary multi-modal device that non-invasively monitors brain activity via electroencephalography (EEG) and brain blood flow via a novel electrocardiography-based metric. The device is designed to provide continuous, real-time monitoring of stroke patients to detect secondary strokes and monitor treatment effectiveness between CT perfusion scans, with future potential for pre-hospital and self-administered remote monitoring.

Is nuroflux a public or private company?

nuroflux is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was nuroflux founded?

nuroflux was founded in 2021. It employs 1 to 10 people.

Where is nuroflux based?

nuroflux is headquartered in Cambridge, United States, in the North America region.

Who are nuroflux's main competitors?

Broad incumbents on record are Edwards Lifesciences, Masimo and Medtronic. Compumedics is listed as a direct peer. Emerging players are Ceribell, BrainScope, NovaSignal, Nonin Medical, iSchemaView (RAPID) and NIRx Medizintechnik.

Does nuroflux have an API?

No public API is recorded for nuroflux.

What industry is nuroflux in?

nuroflux's product category is Neurological Monitoring Medical Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales